Skip to main content
Log in

Correlative study on the expression of p53 and DNA ploidy in acute nonlymphocytic leukemia

  • Published:
Journal of Tongji Medical University Aims and scope Submit manuscript

Summary

We used the flow cytometric immunoassay to study the correlation between the tumor-suppressor gene product p53 and the DNA ploidy in 30de novo cases of acute nonlymphocytic leukemia (ANLL). The results showed that 15 cases were negative and the other 15 cases were positive expression for p53. As compared with p53 negative (p53) cases, the patients with positive p53 (p53+) had higher percentage of bone marrow blasts and lower peripheral leukocyte and platelet counts, which had no influence on the complete remission rate. Before treatment, DNA diploidy was seen in 18 cases including 12 p53 cases, and DNA aneuploidy in 12 cases including 9 p53+. After therapy, aneuploidy could be transformed into diploidy. Patients with P53+ or having aneuploidy in complete remission were at risk for early relapse. We believe that p53 may be involved in the process of leukemogenesis and progression of ANLL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Levine A J, Momand J, Finlay C A. The p53 tumor suppressor gene. Nature, 1991, 351: 453.

    Article  PubMed  CAS  Google Scholar 

  2. Harris C C, Hollstein M. Clinical implication of the p53 tumor-suppressor gene. N Eng J Med, 1993, 329:1318.

    Article  CAS  Google Scholar 

  3. Zhang R X, Yao E G. The prognostic significance of flow cytometry DNA measurement in acute leukemia. Chin J Hematol, 1989, 10:415.

    CAS  Google Scholar 

  4. Zhang R X, Yao E G. Flow cytometry DNA measurement for prediction of effect of therapy in acute leukemia. J Tongji Med Uni, 1990, 10: 181.

    Article  CAS  Google Scholar 

  5. Zhang R X, Yao E G. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia. Chin Med J, 1990, 103: 826.

    PubMed  CAS  Google Scholar 

  6. Danova M, Giordano M, Mazzini Get al. Expression of p53 protein during the cell cycles measured by flow cytometry in human leukemia. Leu Res, 1990, 14:417.

    Article  CAS  Google Scholar 

  7. Qi F Y, Qing T W, Liu X Yet al. Study on the expression of ras oncogene product p21 and DNA ploidy in oral squamous cell carcinoma. Chin J Phy Med, 1993, 15:24.

    Google Scholar 

  8. Smith L J, McCulloch A M, Benchimol S. Expression of the p53 oncogene in acute myeloblastic leukemia. J Exp Med, 1986, 164: 751.

    Article  PubMed  CAS  Google Scholar 

  9. Langois R G, Bigbee W L, Jensen R H. Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum Genet, 1986, 74:353.

    Article  Google Scholar 

  10. Bighee W L, Wyrobek A J, Langois R Get al. The effect of chemotherapy on the in vivo frequency of glycophorin A “ null” variant erythrocytes. Mut Res, 1990, 240:165.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng-ru, L., Er-gu, Y., Lian-fu, Z. et al. Correlative study on the expression of p53 and DNA ploidy in acute nonlymphocytic leukemia. Journal of Tongji Medical University 15, 143–146 (1995). https://doi.org/10.1007/BF02888222

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02888222

Key words

Navigation